• Asian Connection
    Asian Connection
* Pandemic to be 'far more deadly' this year, WHO warns    * Andhra Arrests MP For Sedition After He Says 'Cancel Chief Minister's Bail'    * Israel launches more strikes on Gaza as fears of a ground invasion grow    * RCMP searching for suspect in racist tirade at B.C. drive-thru    * RCMP searching for suspect in racist tirade at B.C. drive-thru    * RCMP searching for suspect in racist tirade at B.C. drive-thru

Johnson & Johnson Seeks India’s Permission For Phase 3 Trial Of 1-Shot Vaccine.

Posted in Featured, S. Asia

Published on April 19, 2021 with No Comments

Johnson & Johnson’s vaccine is a single-dose jab, whereas the three vaccines cleared by India so far are of doubles doses.

Multinational pharma giant Johnson & Johnson has applied to India’s drug regulator seeking permission to conduct phase-3 clinical trial of its single-dose COVID-19 vaccine in India as well as import licence, sources said.

They said the company has sought an early meeting of the subject expert committee on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) to take a decision on its application.

This comes close to the heels of the central government last week deciding to fast-track emergency approvals for all foreign produced coronavirus jabs that have been given a similar nod by the World Health Organization or regulators in the United States, Europe, Britain or Japan.

Such vaccines will be given emergency use approval mandating the requirement of post-approval parallel bridging clinical trial in place of conduct of local clinical trial under the provisions of the New Drugs and Clinical Trials Rules 2019, the health ministry had said.

According to sources, Johnson & Johnson had applied on April 12 in the Global Clinical Trial Division through the Sugam online portal, instead of applying to the biological division which deals with vaccines and other biologicals.

“Due to the technicalities involved, Johnson & Johnson has resubmitted its application on Monday,” a source said.

The J&J vaccine can be stored for up to three months in a temperature between 2 and 8 degrees Celsius.

Johnson & Johnson’s vaccine is a single-dose jab, whereas the three vaccines cleared by India so far are of doubles doses.

So far, two vaccines — Oxford/Astrazeneca vaccine COVISHIELD manufactured by Serum Institute in India and indigenously developed COVAXIN by Bharat Biotech — are being administered in India, while a third vaccine Sputnik V — developed in Russia and to be imported and sold in India by Dr Reddy’s Laboratories — has also been approved by the Indian drug regulator.

The government, meanwhile, on Monday decided to expand its vaccination drive by allowing everyone above 18 years of age eligible to be vaccinated from May 1 and permitted state governments, private hospitals and industrial establishments to procure the doses directly from manufacturers.

 

No Comments

Comments for Johnson & Johnson Seeks India’s Permission For Phase 3 Trial Of 1-Shot Vaccine. are now closed.